[go: up one dir, main page]

CN111686809A - Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof - Google Patents

Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof Download PDF

Info

Publication number
CN111686809A
CN111686809A CN202010570195.9A CN202010570195A CN111686809A CN 111686809 A CN111686809 A CN 111686809A CN 202010570195 A CN202010570195 A CN 202010570195A CN 111686809 A CN111686809 A CN 111686809A
Authority
CN
China
Prior art keywords
carbonyl reductase
isopropanol dehydrogenase
isopropanol
preparation
immobilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010570195.9A
Other languages
Chinese (zh)
Inventor
陈芬儿
黄则度
胡辰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fudan University
Original Assignee
Fudan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fudan University filed Critical Fudan University
Priority to CN202010570195.9A priority Critical patent/CN111686809A/en
Publication of CN111686809A publication Critical patent/CN111686809A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/003Catalysts comprising hydrides, coordination complexes or organic compounds containing enzymes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/06Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/643Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明属于生物制药技术领域,具体公开一种羰基还原酶/异丙醇脱氢酶共固载催化剂及其制备方法和应用。本发明将羰基还原酶和异丙醇脱氢酶共包埋于由聚乙烯醇和聚乙二醇所得的固相载体中,所得共固载酶催化剂通过羰基还原酶的催化以及异丙醇脱氢酶对于辅酶NADPH的循环,可实现3‑羰基‑5‑己烯酸酯的高效、高立体选择性还原生成(R)‑3‑羟基‑5‑己烯酸酯。该催化剂可用于以3‑羰基‑5‑己烯酸酯为底物制备(R)‑3‑羟基‑5‑己烯酸酯中,本发明方法制备的共固载催化剂催化效率高、稳定性好、可重复使用、工艺简洁、成本低廉,具有优良的实际工业应用价值。

Figure 202010570195

The invention belongs to the technical field of biopharmaceuticals, and specifically discloses a carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and a preparation method and application thereof. In the present invention, carbonyl reductase and isopropanol dehydrogenase are co-embedded in a solid phase carrier obtained from polyvinyl alcohol and polyethylene glycol, and the obtained co-immobilized enzyme catalyst is catalyzed by carbonyl reductase and isopropanol dehydrogenation. The enzyme can achieve efficient and high stereoselective reduction of 3-carbonyl-5-hexenoate to generate ( R )-3-hydroxy-5-hexenoate in the cycle of coenzyme NADPH. The catalyst can be used to prepare ( R )-3-hydroxy-5-hexenoate by using 3-carbonyl-5-hexenoate as a substrate, and the co-immobilized catalyst prepared by the method of the present invention has high catalytic efficiency and stability It is good, reusable, simple in process, low in cost, and has excellent practical industrial application value.

Figure 202010570195

Description

羰基还原酶/异丙醇脱氢酶共固载催化剂及其制备方法和 应用Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method thereof application

技术领域technical field

本发明属于生物制药技术领域,具体涉及共固载酶催化剂及其制备方法和在合成(R)-3-羟基-5-己烯酸酯中的应用。The invention belongs to the technical field of biopharmaceuticals, and particularly relates to a co-immobilized enzyme catalyst, a preparation method thereof, and an application in the synthesis of ( R )-3-hydroxy-5-hexenoate.

背景技术Background technique

R)-3-羟基-5-己烯酸酯是一种被广泛应用于医药化工中间体包括他汀类降血脂药物合成的重要手性化合物,其结构式如下图(I)所示,式中R为C1-C8烷基或环烷基,单取代或多取代芳基或芳烷基。( R )-3-Hydroxy-5-hexenoate is an important chiral compound widely used in the synthesis of pharmaceutical and chemical intermediates including statins hypolipidemic drugs. Its structural formula is shown in Figure (I) below, in which R is C 1 -C 8 alkyl or cycloalkyl, mono- or polysubstituted aryl or aralkyl.

Figure 100002_DEST_PATH_IMAGE002
Figure 100002_DEST_PATH_IMAGE002

作为目前合成化合物(I)及其结构类似物的主要途径,化学方法存在其不足之处,例如常需要用到极端反应条件,包括-20oC至-50oC低温(美国专利US6355822)和高氢气压力(欧洲专利EP1176135)等。这些苛刻的反应条件严重地限制了化学方法制备该类化合物的工业前景。As the main way to synthesize compound (I) and its structural analogs, chemical methods have their shortcomings, such as extreme reaction conditions, including -20 o C to -50 o C low temperature (US patent US6355822) and High hydrogen pressure (European patent EP1176135), etc. These harsh reaction conditions severely limit the industrial prospects of chemical preparation of such compounds.

本团队报道了利用羰基还原酶催化还原化合物(II),高效、高立体选择性(>99%ee)地生成(R)-3-羟基-5-己烯酸酯(I)(中国专利申请CN107119081A、美国专利US10526622)。与传统化学方法相比,该方法具有反应条件温和、反应收率高的优点,具备良好的工业应用价值。但是,在该报道中用于催化反应的羰基还原酶和用于辅酶再生的异丙醇脱氢酶都是粗酶液,使反应后处理变得繁琐,且由于酶催化剂难以回收、重复使用,增加了工业生产成本。Our team reported the efficient and stereoselective (>99% ee ) reduction of compound (II) by carbonyl reductase to generate ( R )-3-hydroxy-5-hexenoate (I) (Chinese Patent Application CN107119081A, US patent US10526622). Compared with the traditional chemical method, the method has the advantages of mild reaction conditions and high reaction yield, and has good industrial application value. However, in this report, the carbonyl reductase used for the catalytic reaction and the isopropanol dehydrogenase used for the regeneration of the coenzyme are both crude enzyme liquids, which make the post-reaction treatment complicated, and because the enzyme catalyst is difficult to recover and reuse, Increased industrial production costs.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种催化效率高、稳定性好的羰基还原酶/异丙醇脱氢酶共固载催化剂及其制备方法和在合成(R)-3-羟基-5-己烯酸酯中的应用。The object of the present invention is to provide a carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst with high catalytic efficiency and good stability and a preparation method thereof and a method for synthesizing ( R )-3-hydroxy-5-hexenoic acid ester applications.

本发明提供的羰基还原酶/异丙醇脱氢酶共固载催化剂的制备方法,具体步骤为:The preparation method of the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst provided by the invention comprises the following steps:

步骤1:将聚乙烯醇及聚乙二醇配成一定浓度的水溶液,加热溶清,降温至50℃以下;Step 1: prepare polyvinyl alcohol and polyethylene glycol into an aqueous solution of a certain concentration, heat to dissolve, and cool down to below 50 °C;

步骤2:加入一定比例的羰基还原酶粗酶液及异丙醇脱氢酶粗酶液(粗酶液的制备方法见我们前期中国专利申请CN107119081A)于步骤1所得溶液中,混合均匀;Step 2: Add a certain proportion of carbonyl reductase crude enzyme solution and isopropanol dehydrogenase crude enzyme solution (see our previous Chinese patent application CN107119081A for the preparation method of the crude enzyme solution) in the solution obtained in step 1, and mix evenly;

步骤3:混合结束后,用注射器将溶液滴加至聚乙烯薄膜上,然后置于35-40℃鼓风烘箱中干燥一定时间,即得羰基还原酶/异丙醇脱氢酶共固载催化剂,将其贮存于4℃备用。Step 3: After mixing, drop the solution onto the polyethylene film with a syringe, and then place it in a forced air oven at 35-40°C to dry for a certain period of time to obtain a co-immobilized catalyst for carbonyl reductase/isopropanol dehydrogenase , and stored at 4°C until use.

其中,羰基还原酶的氨基酸序列如SEQ ID NO.1所示,异丙醇脱氢酶的氨基酸序列如SEQ ID NO.2所示。The amino acid sequence of carbonyl reductase is shown in SEQ ID NO.1, and the amino acid sequence of isopropanol dehydrogenase is shown in SEQ ID NO.2.

本发明步骤1中,优选地,所述聚乙烯醇与聚乙二醇的用量质量比为5:3-5:1,更优选为5:3-5:2。In step 1 of the present invention, preferably, the amount-to-mass ratio of the polyvinyl alcohol to polyethylene glycol is 5:3-5:1, more preferably 5:3-5:2.

本发明步骤2中,优选地,所用羰基还原酶粗酶液及异丙醇脱氢酶粗酶液的初始浓度均为10%-30%(w/v),更优选为15%-20%(w/v)。In step 2 of the present invention, preferably, the initial concentrations of the crude carbonyl reductase enzyme solution and the crude isopropanol dehydrogenase enzyme solution are both 10%-30% (w/v), more preferably 15%-20% (w/v).

本发明步骤2中,优选地,所用羰基还原酶粗酶液、异丙醇脱氢酶粗酶液、聚乙烯醇/聚乙二醇水溶液的体积比为2:1:5-2:1:10,更优选为2:1:5-2:1:7。In step 2 of the present invention, preferably, the volume ratio of the crude carbonyl reductase enzyme solution, the crude isopropanol dehydrogenase enzyme solution, and the polyvinyl alcohol/polyethylene glycol aqueous solution is 2:1:5-2:1: 10, more preferably 2:1:5-2:1:7.

本发明步骤3中,所述干燥时间为0.5-1h。In step 3 of the present invention, the drying time is 0.5-1 h.

本发明将羰基还原酶和异丙醇脱氢酶共包埋于由聚乙烯醇和聚乙二醇所得的固相载体中,所得共固载酶催化剂通过羰基还原酶的催化以及异丙醇脱氢酶对于辅酶NADPH的循环,实现3-羰基-5-己烯酸酯(II)的高效、高立体选择性还原生成(R)-3-羟基-5-己烯酸酯(I)。In the present invention, carbonyl reductase and isopropanol dehydrogenase are co-embedded in a solid phase carrier obtained from polyvinyl alcohol and polyethylene glycol, and the obtained co-immobilized enzyme catalyst is catalyzed by carbonyl reductase and isopropanol dehydrogenation. Enzyme for the recycling of coenzyme NADPH to achieve efficient and highly stereoselective reduction of 3-carbonyl-5-hexenoate (II) to generate ( R )-3-hydroxy-5-hexenoate (I).

本发明制备的共固载酶催化剂,可用于以3-羰基-5-己烯酸酯(II)为底物制备(R)-3-羟基-5-己烯酸酯(I)中,具体步骤为:The co-immobilized enzyme catalyst prepared by the invention can be used for preparing ( R )-3-hydroxy-5-hexenoate (I) by using 3-carbonyl-5-hexenoate (II) as a substrate, specifically The steps are:

将共固载酶催化剂、磷酸盐缓冲液、异丙醇、辅酶NADP+与底物3-羰基-5-己烯酸酯(II)混合,经催化反应,反应液的pH为6-9,反应温度为15-35oC,制得(R)-3-羟基-5-己烯酸酯(I);The co-immobilized enzyme catalyst, phosphate buffer, isopropanol, coenzyme NADP + and the substrate 3-carbonyl-5-hexenoate (II) were mixed, and the pH of the reaction solution was 6-9 after catalytic reaction. The reaction temperature is 15-35 o C to obtain ( R )-3-hydroxy-5-hexenoate (I);

本发明的反应式为:Reaction formula of the present invention is:

Figure DEST_PATH_IMAGE004
Figure DEST_PATH_IMAGE004

式中,R为C1-C8烷基或环烷基,单取代或多取代芳基或芳烷基。In the formula, R is C 1 -C 8 alkyl or cycloalkyl, mono- or poly-substituted aryl or aralkyl.

如上述反应式所示,反应中底物3-羰基-5-己烯酸酯(II)在共固载酶催化剂的催化下发生还原反应生成产物(R)-3-羟基-5-己烯酸酯(I),反应结束后,从反应液中分离纯化,即得到目标产物。As shown in the above reaction formula, in the reaction, the substrate 3-carbonyl-5-hexenoate (II) undergoes a reduction reaction under the catalysis of the co-immobilized enzyme catalyst to generate the product ( R )-3-hydroxy-5-hexene The acid ester (I), after the completion of the reaction, is separated and purified from the reaction solution to obtain the target product.

优选地,在起始反应体系中,底物的质量百分浓度为1%-30%(w/v),更优选为10%-20%。Preferably, in the initial reaction system, the mass percentage concentration of the substrate is 1%-30% (w/v), more preferably 10%-20%.

优选地,在起始反应体系中,异丙醇的百分浓度为5%-25%(v/v),更优选为10%-20%。Preferably, in the initial reaction system, the percentage concentration of isopropanol is 5%-25% (v/v), more preferably 10%-20%.

优选地,所述共固载酶催化剂的用量为底物质量的20%-100%(w/w),更优选为50%-100%。Preferably, the amount of the co-immobilized enzyme catalyst is 20%-100% (w/w) of the mass of the substrate, more preferably 50%-100%.

优选地,所述辅酶NADP+的用量为底物用量的0.003%-0.01%(w/w)。Preferably, the amount of the coenzyme NADP + is 0.003%-0.01% (w/w) of the amount of the substrate.

优选地,所述反应温度为25-30oC;Preferably, the reaction temperature is 25-30 ;

优选地,反应液的pH为6.5-7.5。Preferably, the pH of the reaction solution is 6.5-7.5.

上述反应结束后,对反应液进行后处理,获得成品,所述后处理为:过滤分离共固载酶催化剂,滤液用乙酸乙酯萃取3次;合并有机层,用水、饱和食盐水分别洗涤,用无水硫酸钠干燥,减压浓缩至干,得产物成品。After the above reaction is completed, the reaction solution is subjected to post-processing to obtain a finished product. The post-processing is as follows: filtration and separation of the co-immobilized enzyme catalyst, and the filtrate is extracted three times with ethyl acetate; the organic layers are combined and washed with water and saturated brine respectively, Dry with anhydrous sodium sulfate and concentrate to dryness under reduced pressure to obtain the finished product.

与现有技术相比,本发明催化剂催化效率高、稳定性好、可重复使用,经对共固载催化剂与游离酶在温度稳定性、pH稳定性、可重复使用次数等方面的比较,共固载酶催化剂都体现出了更为优异的稳定性和催化效率。本发明工艺简洁、成本低廉,具有重大工业应用价值。Compared with the prior art, the catalyst of the present invention has high catalytic efficiency, good stability, and can be reused. By comparing the co-immobilized catalyst and the free enzyme in terms of temperature stability, pH stability, and reusable times, the total The immobilized enzyme catalysts showed more excellent stability and catalytic efficiency. The invention has simple process, low cost and great industrial application value.

附图说明Description of drawings

图1为异丙醇脱氢酶游离酶和共固载酶催化剂的温度稳定性曲线。Figure 1 shows the temperature stability curves of isopropanol dehydrogenase free enzyme and co-immobilized enzyme catalyst.

图2为羰基还原酶游离酶和共固载酶催化剂的温度稳定性曲线。Figure 2 shows the temperature stability curves of carbonyl reductase free enzyme and co-immobilized enzyme catalysts.

图3为异丙醇脱氢酶游离酶和共固载酶催化剂的pH稳定性曲线。Figure 3 is the pH stability curve of isopropanol dehydrogenase free enzyme and co-immobilized enzyme catalyst.

图4为羰基还原酶游离酶和共固载酶催化剂的pH稳定性曲线。Figure 4 shows the pH stability curves of carbonyl reductase free enzyme and co-immobilized enzyme catalysts.

图5为异丙醇脱氢酶游离酶、羰基还原酶游离酶和共固载酶催化剂的储存稳定性曲线。Figure 5 shows the storage stability curves of isopropanol dehydrogenase free enzyme, carbonyl reductase free enzyme and co-immobilized enzyme catalysts.

图6为共固载催化剂的重复使用性能研究。Figure 6 is a study on the reuse performance of the co-immobilized catalyst.

具体实施方式Detailed ways

下面结合具体实施例对本发明做进一步详细地说明,但本发明并不限于以下实施例。The present invention will be described in further detail below with reference to specific embodiments, but the present invention is not limited to the following embodiments.

实施例1,羰基还原酶/异丙醇脱氢酶共固载催化剂的制备Embodiment 1, the preparation of carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst

称取5g聚乙烯醇、3g聚乙二醇及35mL水置于反应瓶中,加热至溶液澄清,降温至50℃以下,加入10mL羰基还原酶粗酶液(15% w/v)及5mL异丙醇脱氢酶粗酶液(15% w/v),混合均匀。混合结束后,用注射器将溶液滴加至聚乙烯薄膜上,然后置于35-40℃鼓风烘箱中干燥1h,既得羰基还原酶/异丙醇脱氢酶共固载催化剂,将其贮存于4℃备用。Weigh 5 g of polyvinyl alcohol, 3 g of polyethylene glycol and 35 mL of water into a reaction flask, heat until the solution is clear, cool down to below 50 °C, add 10 mL of crude carbonyl reductase enzyme solution (15% w/v) and 5 mL of isopropyl alcohol. Propanol dehydrogenase crude enzyme solution (15% w/v), mix well. After mixing, the solution was added dropwise to the polyethylene film with a syringe, and then placed in a blast oven at 35-40 °C for 1 h to obtain the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst, which was stored in Reserve at 4°C.

实施例2,羰基还原酶/异丙醇脱氢酶共固载催化剂的热稳定性研究Example 2, Thermal stability study of carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst

取羰基还原酶游离酶(粗酶液)、异丙醇脱氢酶游离酶(粗酶液)和实施例1制得的羰基还原酶/异丙醇脱氢酶共固载催化剂,分别于20℃、30℃、40℃、50℃、60℃、70℃、80℃下保温30min,然后分别测定酶活力,以最高活性为100%,平行测定三次,作相应的温度稳定性曲线,如图1和2所示。Take carbonyl reductase free enzyme (crude enzyme solution), isopropanol dehydrogenase free enzyme (crude enzyme solution) and the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst prepared in Example 1, respectively, at 20 ℃、30℃、40℃、50℃、60℃、70℃、 80 1 and 2 are shown.

羰基还原酶的酶活测定方法:取一定量的羰基还原酶游离酶或固定化酶,加入到含底物(10 mM)、NADPH(0.24 mM)的磷酸盐缓冲溶液中(100 mM, pH 7.5),震荡1min后,离心,取上清液测得340 nm下的吸光度变化,计算得每克酶的酶活。Enzyme activity determination method of carbonyl reductase: take a certain amount of carbonyl reductase free enzyme or immobilized enzyme and add it to a phosphate buffer solution (100 mM, pH 7.5) containing substrate (10 mM) and NADPH (0.24 mM). ), shake for 1 min, centrifuge, take the supernatant to measure the change of absorbance at 340 nm, and calculate the enzyme activity per gram of enzyme.

异丙醇脱氢酶的酶活测定方法:取一定量的异丙醇脱氢酶游离酶或固定化酶,加入到含异丙醇(2% v/v)、NADP+(0.4 mM)的磷酸盐缓冲溶液中(100 mM, pH 7.5),震荡1min后,离心,取上清液测得340 nm下的吸光度变化,计算得每克酶的酶活。Determination method of the enzyme activity of isopropanol dehydrogenase: take a certain amount of isopropanol dehydrogenase free enzyme or immobilized enzyme, add it to the solution containing isopropanol (2% v/v), NADP + (0.4 mM). In phosphate buffer solution (100 mM, pH 7.5), after shaking for 1 min, centrifuge, take the supernatant to measure the change of absorbance at 340 nm, and calculate the enzyme activity per gram of enzyme.

由图1和2可知,对于异丙醇脱氢酶酶活而言,游离酶在50℃以上失去活性,而固定化酶在80℃依然保有20%的活性,且在40℃-80℃温度范围内固定化酶的温度稳定性高于游离酶。对于羰基还原酶而言,固定化酶在30-70℃温度范围内的温度稳定性高于游离酶。该结果表明:在高温环境中,羰基还原酶/异丙醇脱氢酶共固载催化剂比异丙醇脱氢酶、羰基还原酶的游离酶更加稳定,能更好地保持催化活力。It can be seen from Figures 1 and 2 that for the enzyme activity of isopropanol dehydrogenase, the free enzyme loses its activity at temperatures above 50 °C, while the immobilized enzyme still retains 20% of its activity at 80 °C, and at a temperature of 40 °C to 80 °C. The temperature stability of the immobilized enzyme in the range is higher than that of the free enzyme. For carbonyl reductase, the temperature stability of the immobilized enzyme in the temperature range of 30-70 °C is higher than that of the free enzyme. The results show that the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst is more stable than the free enzymes of isopropanol dehydrogenase and carbonyl reductase in high temperature environment, and can better maintain the catalytic activity.

实施例3,羰基还原酶/异丙醇脱氢酶共固载催化剂的pH稳定性研究Example 3, pH stability study of carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst

取羰基还原酶游离酶、异丙醇脱氢酶游离酶和实施例1制得的羰基还原酶/异丙醇脱氢酶共固载催化剂,加入到pH为4、5、6、7、8的缓冲溶液中,在30℃水浴条件下孵育5min,然后分别测定酶活力,以最高活性为100%,平行测定三次,作相应的pH稳定性曲线,如图3和4所示。Take carbonyl reductase free enzyme, isopropanol dehydrogenase free enzyme and carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst prepared in Example 1, add to pH 4, 5, 6, 7, 8 In the buffer solution, incubate in 30℃ water bath for 5min, then measure the enzyme activity respectively, take the highest activity as 100%, measure in parallel three times, and make the corresponding pH stability curve, as shown in Figures 3 and 4.

由图3和4可知,对于异丙醇脱氢酶而言,固定化酶及游离酶在pH=4时都失去活性,而在pH=5-8的情况下,固定化酶的pH稳定性都较游离酶有所提高。对于羰基还原酶而言,固定化酶的pH稳定性在酸性条件下较游离酶有所下降;但在碱性条件下,固定化酶的pH稳定性高于游离酶。该结果表明:在碱性条件下,羰基还原酶/异丙醇脱氢酶共固载催化剂比异丙醇脱氢酶、羰基还原酶的游离酶更加稳定,能更好地保持催化活力。It can be seen from Figures 3 and 4 that for isopropanol dehydrogenase, both the immobilized enzyme and the free enzyme are inactive at pH=4, while in the case of pH=5-8, the pH stability of the immobilized enzyme Both were improved compared with free enzyme. For carbonyl reductase, the pH stability of the immobilized enzyme was lower than that of the free enzyme under acidic conditions; however, the pH stability of the immobilized enzyme was higher than that of the free enzyme under alkaline conditions. The results show that under alkaline conditions, the co-immobilized catalyst of carbonyl reductase/isopropanol dehydrogenase is more stable than the free enzymes of isopropanol dehydrogenase and carbonyl reductase, and can better maintain the catalytic activity.

实施例4,羰基还原酶/异丙醇脱氢酶共固载催化剂的储存稳定性研究Example 4, Storage stability study of carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst

取羰基还原酶游离酶、异丙醇脱氢酶游离酶和实施例1制得的羰基还原酶/异丙醇脱氢酶共固载催化剂,在20℃下放置12天,以最初的活性为100%,分别测定4天以及12天的酶活,得曲线图5。Take carbonyl reductase free enzyme, isopropanol dehydrogenase free enzyme and carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst prepared in Example 1, and place it at 20 ° C for 12 days. The initial activity is 100%, the enzymatic activities of 4 days and 12 days were measured respectively, and curve 5 was obtained.

由图5可知,经过12天的储存,羰基还原酶/异丙醇脱氢酶共固载催化剂的稳定性都高于游离酶。其中,共固载催化剂的羰基还原酶酶活基本没有变化,且其异丙醇脱氢酶的酶活也保持在85%以上。而羰基还原酶游离酶和异丙醇脱氢酶游离酶的活性都降至80%以下,其中异丙醇脱氢酶游离酶的活性只剩60%。该结果表明:固定化酶在室温条件下的储存稳定性比游离酶更为优异,能够长时间储存。It can be seen from Figure 5 that after 12 days of storage, the stability of the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst is higher than that of the free enzyme. Among them, the enzymatic activity of carbonyl reductase of the co-immobilized catalyst remained basically unchanged, and the enzymatic activity of isopropanol dehydrogenase remained above 85%. The activities of carbonyl reductase free enzyme and isopropanol dehydrogenase free enzyme both dropped below 80%, and the activity of isopropanol dehydrogenase free enzyme was only 60%. The results show that the storage stability of the immobilized enzyme at room temperature is better than that of the free enzyme, and it can be stored for a long time.

实施例5,羰基还原酶/异丙醇脱氢酶共固载催化剂的重复使用性能研究Example 5. Research on the reusability of carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst

取实施例1制备的羰基还原酶/异丙醇脱氢酶共固载催化剂(100 mg),加入底物3-羰基-5-己烯酸叔丁酯(100 mg)、异丙醇(0.1 mL)、NADP+(0.01 mg)、磷酸盐缓冲液(50 mM,pH=7.0)(0.4mL),在恒温振荡摇床中反应10h(30℃、200rpm),反应完毕后,通过GC-MS测定底物的转化率,之后过滤回收共固载酶催化剂,冲洗干净。如此重复使用该共固载酶催化剂18次,测定转化率,作重复使用性能图(图6)。Take the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst (100 mg) prepared in Example 1, add the substrate tert-butyl 3-carbonyl-5-hexenoate (100 mg), isopropanol (0.1 mL), NADP + (0.01 mg), phosphate buffer (50 mM, pH=7.0) (0.4 mL), reacted in a constant temperature shaking shaker for 10 h (30 °C, 200 rpm). The conversion rate of the substrate was measured, and then the co-immobilized enzyme catalyst was recovered by filtration and washed. The co-immobilized enzyme catalyst was reused 18 times in this way, the conversion rate was measured, and the reuse performance chart was drawn (Fig. 6).

由图6可知,固定化后的酶在重复使用10次后,底物转化率基本稳定(>98%);在重复使用18次后,底物转化率依然保持在85%以上。该结果表明:酶包埋在固定化载体中比较稳定,不易脱落,且酶活性保持稳定,可实现重复使用。It can be seen from Figure 6 that the substrate conversion rate of the immobilized enzyme is basically stable (>98%) after 10 repeated use; after 18 repeated use, the substrate conversion rate still remains above 85%. The results show that the enzyme embedded in the immobilized carrier is relatively stable, not easy to fall off, and the enzyme activity remains stable, which can be reused.

实施例6,羰基还原酶/异丙醇脱氢酶共固载催化剂催化不对称还原生成(R)-3-羟基-5-己烯酸叔丁酯(克级)Example 6, Carbonyl reductase/isopropanol dehydrogenase co-supported catalyst catalyzed asymmetric reduction to generate ( R )-3-hydroxy-5-hexenoic acid tert-butyl ester (gram scale)

取实施例1制备的羰基还原酶/异丙醇脱氢酶共固载催化剂(1g),加入底物3-羰基-5-己烯酸叔丁酯(1g)、异丙醇(1 mL)、NADP+(0.1 mg)、磷酸盐缓冲液(50 mM, pH=7.0)(4mL),在恒温振荡摇床中反应10h(30℃、200rpm),反应完毕后,过滤回收共固载酶催化剂。滤液用乙酸乙酯萃取3次,合并有机层,用水、饱和食盐水分别洗涤,无水硫酸钠干燥,减压浓缩至干得产物成品0.91 g(收率90%,ee值99.7%)。1H NMR (CDCl3, 400 MHz): δ/ppm 5.82 (m,1H), 5.06 (d, J = 6.4 Hz, 1H), 5.02 (s, 1H), 3.97 (m, 1H),2.40-2.14 (m, 4H),1.39 (s, 9H)。Take the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst (1 g) prepared in Example 1, and add the substrate tert-butyl 3-carbonyl-5-hexenoate (1 g) and isopropanol (1 mL) , NADP + (0.1 mg), phosphate buffer (50 mM, pH=7.0) (4 mL), react in a constant temperature shaking shaker for 10 h (30 °C, 200 rpm), after the reaction, filter and recover the co-immobilized enzyme catalyst . The filtrate was extracted three times with ethyl acetate, the organic layers were combined, washed with water and saturated brine respectively, dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure to obtain 0.91 g of the finished product (yield 90%, ee value 99.7%). 1 H NMR (CDCl 3 , 400 MHz): δ/ppm 5.82 (m, 1H), 5.06 (d, J = 6.4 Hz, 1H), 5.02 (s, 1H), 3.97 (m, 1H), 2.40-2.14 (m, 4H), 1.39 (s, 9H).

实施例7,羰基还原酶/异丙醇脱氢酶共固载催化剂催化不对称还原生成(R)-3-羟基-5-己烯酸甲酯(克级)Example 7, Carbonyl reductase/isopropanol dehydrogenase co-supported catalyst catalyzed asymmetric reduction to generate ( R )-3-hydroxy-5-hexenoic acid methyl ester (gram scale)

取实施例1制备的羰基还原酶/异丙醇脱氢酶共固载催化剂(1g),加入底物3-羰基-5-己烯酸甲酯(1g)、异丙醇(0.8 mL)、NADP+(0.07 mg)、磷酸盐缓冲液(50 mM, pH=7.0)(4mL),在恒温振荡摇床中反应12h(30℃、200rpm),反应完毕后,过滤回收共固载酶催化剂。滤液用乙酸乙酯萃取3次,合并有机层,用水、饱和食盐水分别洗涤,无水硫酸钠干燥,减压浓缩至干得产物成品0.90 g(收率89%,ee值99.8%)。1H NMR (CDCl3, 400 MHz): δ/ppm5.81 (m, 1H), 5.14 (d, J = 4.6 Hz, 1H), 5.10 (s, 1H), 4.07 (m, 1H),3.70 (s,3H),2.48-2.24 (m, 4H)。Take the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst (1 g) prepared in Example 1, add the substrate 3-carbonyl-5-hexenoic acid methyl ester (1 g), isopropanol (0.8 mL), NADP + (0.07 mg), phosphate buffer (50 mM, pH=7.0) (4 mL) were reacted in a constant temperature shaking shaker for 12 h (30 °C, 200 rpm). After the reaction, the co-immobilized enzyme catalyst was recovered by filtration. The filtrate was extracted three times with ethyl acetate, the organic layers were combined, washed with water and saturated brine respectively, dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure to obtain 0.90 g of the finished product (yield 89%, ee value 99.8%). 1 H NMR (CDCl 3 , 400 MHz): δ/ppm 5.81 (m, 1H), 5.14 (d, J = 4.6 Hz, 1H), 5.10 (s, 1H), 4.07 (m, 1H), 3.70 ( s, 3H), 2.48-2.24 (m, 4H).

以上所述仅为本发明的较佳实施例,只为说明本发明的技术构思和特点,其目的在于让熟悉此项技术的人士能够了解本发明的内容并据以实施,并不能以此限制本发明的保护范围。凡根据本发明精神实质所作的任何修改、等同替换、改进等,都应涵盖在本发明的保护范围之内。The above is only the preferred embodiment of the present invention, only to illustrate the technical concept and characteristics of the present invention, and its purpose is to enable those who are familiar with the technology to understand the content of the present invention and implement it accordingly, and it should not be limited by this. protection scope of the present invention. Any modification, equivalent replacement, improvement, etc. made according to the spirit of the present invention shall be included within the protection scope of the present invention.

序列表sequence listing

<110> 复旦大学<110> Fudan University

<120> 羰基还原酶/异丙醇脱氢酶共固载催化剂及其制备方法和应用<120> Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and its preparation method and application

<130> 001<130> 001

<160> 2<160> 2

<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0

<210> 1<210> 1

<211> 252<211> 252

<212> PRT<212> PRT

<213> 人工序列(Artificial Sequence)<213> Artificial Sequence

<400> 1<400> 1

Met Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly ThrMet Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly Thr

1 5 10 151 5 10 15

Leu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly AlaLeu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly Ala

20 25 30 20 25 30

Lys Val Val Ile Thr Gly Arg Arg Ala Asp Val Gly Glu Arg Ala AlaLys Val Val Ile Thr Gly Arg Arg Ala Asp Val Gly Glu Arg Ala Ala

35 40 45 35 40 45

Lys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Ile Gln His Asp AlaLys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Ile Gln His Asp Ala

50 55 60 50 55 60

Ser Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu AlaSer Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu Ala

65 70 75 8065 70 75 80

Phe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Asp Val ValPhe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Asp Val Val

85 90 95 85 90 95

Lys Ser Val Glu Asp Thr Thr Thr Glu Glu Trp His Lys Leu Leu SerLys Ser Val Glu Asp Thr Thr Thr Glu Glu Trp His Lys Leu Leu Ser

100 105 110 100 105 110

Val Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln ArgVal Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln Arg

115 120 125 115 120 125

Met Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser IleMet Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser Ile

130 135 140 130 135 140

Phe Gly Met Val Gly Asp Pro Thr Val Gly Ala Tyr Asn Ala Ser LysPhe Gly Met Val Gly Asp Pro Thr Val Gly Ala Tyr Asn Ala Ser Lys

145 150 155 160145 150 155 160

Gly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala LeuGly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala Leu

165 170 175 165 170 175

Lys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Pro Ile LysLys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Pro Ile Lys

180 185 190 180 185 190

Thr Pro Met Leu Asp Asp Val Glu Gly Ala Glu Glu Met Trp Ser GlnThr Pro Met Leu Asp Asp Val Glu Gly Ala Glu Glu Met Trp Ser Gln

195 200 205 195 200 205

Arg Thr Lys Thr Pro Met Gly His Ile Gly Glu Pro Asn Asp Ile AlaArg Thr Lys Thr Pro Met Gly His Ile Gly Glu Pro Asn Asp Ile Ala

210 215 220 210 215 220

Trp Val Cys Val Tyr Leu Ala Ser Gly Glu Ser Lys Phe Ala Thr GlyTrp Val Cys Val Tyr Leu Ala Ser Gly Glu Ser Lys Phe Ala Thr Gly

225 230 235 240225 230 235 240

Ala Glu Phe Val Ile Asp Gly Gly Trp Thr Ala GlnAla Glu Phe Val Ile Asp Gly Gly Trp Thr Ala Gln

245 250 245 250

<210> 2<210> 2

<211> 252<211> 252

<212> PRT<212> PRT

<213> 人工序列(Artificial Sequence)<213> Artificial Sequence

<400> 2<400> 2

Met Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly ThrMet Thr Asp Arg Leu Lys Gly Lys Val Ala Ile Val Thr Gly Gly Thr

1 5 10 151 5 10 15

Leu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly AlaLeu Gly Ile Gly Leu Ala Ile Ala Asp Lys Phe Val Glu Glu Gly Ala

20 25 30 20 25 30

Lys Val Val Ile Thr Gly Arg His Ala Asp Val Gly Glu Lys Ala AlaLys Val Val Ile Thr Gly Arg His Ala Asp Val Gly Glu Lys Ala Ala

35 40 45 35 40 45

Lys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Val Gln His Asp AlaLys Ser Ile Gly Gly Thr Asp Val Ile Arg Phe Val Gln His Asp Ala

50 55 60 50 55 60

Ser Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu AlaSer Asp Glu Ala Gly Trp Thr Lys Leu Phe Asp Thr Thr Glu Glu Ala

65 70 75 8065 70 75 80

Phe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Ala Val SerPhe Gly Pro Val Thr Thr Val Val Asn Asn Ala Gly Ile Ala Val Ser

85 90 95 85 90 95

Lys Ser Val Glu Asp Thr Thr Thr Glu Glu Trp Arg Lys Leu Leu SerLys Ser Val Glu Asp Thr Thr Thr Glu Glu Trp Arg Lys Leu Leu Ser

100 105 110 100 105 110

Val Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln ArgVal Asn Leu Asp Gly Val Phe Phe Gly Thr Arg Leu Gly Ile Gln Arg

115 120 125 115 120 125

Met Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser IleMet Lys Asn Lys Gly Leu Gly Ala Ser Ile Ile Asn Met Ser Ser Ile

130 135 140 130 135 140

Glu Gly Phe Val Gly Asp Pro Thr Leu Gly Ala Tyr Asn Ala Ser LysGlu Gly Phe Val Gly Asp Pro Thr Leu Gly Ala Tyr Asn Ala Ser Lys

145 150 155 160145 150 155 160

Gly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala LeuGly Ala Val Arg Ile Met Ser Lys Ser Ala Ala Leu Asp Cys Ala Leu

165 170 175 165 170 175

Lys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Tyr Ile LysLys Asp Tyr Asp Val Arg Val Asn Thr Val His Pro Gly Tyr Ile Lys

180 185 190 180 185 190

Thr Pro Leu Val Asp Asp Leu Glu Gly Ala Glu Glu Met Met Ser GlnThr Pro Leu Val Asp Asp Leu Glu Gly Ala Glu Glu Met Met Ser Gln

195 200 205 195 200 205

Arg Thr Lys Thr Pro Met Gly His Ile Gly Glu Pro Asn Asp Ile AlaArg Thr Lys Thr Pro Met Gly His Ile Gly Glu Pro Asn Asp Ile Ala

210 215 220 210 215 220

Trp Ile Cys Val Tyr Leu Ala Ser Asp Glu Ser Lys Phe Ala Thr GlyTrp Ile Cys Val Tyr Leu Ala Ser Asp Glu Ser Lys Phe Ala Thr Gly

225 230 235 240225 230 235 240

Ala Glu Phe Val Val Asp Gly Gly Tyr Thr Ala GlnAla Glu Phe Val Val Asp Gly Gly Tyr Thr Ala Gln

245 250 245 250

Claims (10)

1.一种羰基还原酶/异丙醇脱氢酶共固载催化剂的制备方法,其特征在于,具体步骤为:1. a preparation method of carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst, is characterized in that, concrete steps are: 步骤1:将聚乙烯醇及聚乙二醇配制成水溶液,加热溶清,降温至50℃以下;Step 1: prepare an aqueous solution of polyvinyl alcohol and polyethylene glycol, heat to dissolve, and cool down to below 50°C; 步骤2:加入羰基还原酶粗酶液及异丙醇脱氢酶粗酶液于步骤1所得溶液中,混合均匀;Step 2: Add the crude enzyme solution of carbonyl reductase and the crude enzyme solution of isopropanol dehydrogenase to the solution obtained in step 1, and mix them evenly; 步骤3:混合结束后,用注射器将溶液滴加至聚乙烯薄膜上,然后置于35-40℃鼓风烘箱中干燥,即得羰基还原酶/异丙醇脱氢酶共固载催化剂,贮存备用。Step 3: After mixing, drop the solution onto the polyethylene film with a syringe, and then place it in a forced air oven at 35-40°C to dry to obtain a carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst, which is then stored. spare. 2.根据权利要求1所述的制备方法,其特征在于,步骤1中所述聚乙烯醇与聚乙二醇的用量质量比为5:3-5:1。2. preparation method according to claim 1 is characterized in that, the consumption mass ratio of polyvinyl alcohol described in step 1 and polyethylene glycol is 5:3-5:1. 3.根据权利要求1所述的制备方法,其特征在于,步骤2中所用羰基还原酶粗酶液及异丙醇脱氢酶粗酶液的初始浓度均为10%-30%(w/v)。3. preparation method according to claim 1 is characterized in that, the initial concentration of used carbonyl reductase crude enzyme liquid and isopropanol dehydrogenase crude enzyme liquid in step 2 is 10%-30% (w/v ). 4.根据权利要求1所述的制备方法,其特征在于,步骤2中所用羰基还原酶粗酶液、异丙醇脱氢酶粗酶液、聚乙烯醇/聚乙二醇水溶液的体积比为2:1:5-2:1:10。4. preparation method according to claim 1 is characterized in that, the volume ratio of carbonyl reductase crude enzyme liquid, isopropanol dehydrogenase crude enzyme liquid, polyvinyl alcohol/polyethylene glycol aqueous solution used in step 2 is 2:1:5-2:1:10. 5.根据权利要求1所述的制备方法,其特征在于,步骤3中所述干燥时间为0.5-1h。5. The preparation method according to claim 1, wherein the drying time in step 3 is 0.5-1 h. 6.一种由权利要求1-5之一所述制备方法得到的羰基还原酶/异丙醇脱氢酶共固载催化剂。6. A carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst obtained by the preparation method of one of claims 1-5. 7.一种如权利要求6所述的羰基还原酶/异丙醇脱氢酶共固载催化剂在制备(R)-3-羟基-5-己烯酸酯中的应用。7. The application of the carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst according to claim 6 in the preparation of ( R )-3-hydroxy-5-hexenoate. 8.根据权利要求7所述的应用,其特征在于,具体步骤为:8. application according to claim 7, is characterized in that, concrete steps are: 将共固载酶催化剂、磷酸盐缓冲液、异丙醇、辅酶NADP+与底物3-羰基-5-己烯酸酯(II)混合,经催化反应,反应液的pH为6-9,反应温度为15-35oC,制得(R)-3-羟基-5-己烯酸酯(I);The co-immobilized enzyme catalyst, phosphate buffer, isopropanol, coenzyme NADP + and the substrate 3-carbonyl-5-hexenoate (II) were mixed, and the pH of the reaction solution was 6-9 after catalytic reaction. The reaction temperature is 15-35 o C to obtain ( R )-3-hydroxy-5-hexenoate (I); 反应式为:The reaction formula is:
Figure DEST_PATH_IMAGE002
Figure DEST_PATH_IMAGE002
式中,R为C1-C8烷基或环烷基,单取代或多取代芳基或芳烷基。In the formula, R is C 1 -C 8 alkyl or cycloalkyl, mono- or poly-substituted aryl or aralkyl.
9.根据权利要求8所述的应用,其特征在于,在起始反应体系中,底物的质量百分浓度为1%-30%(w/v);异丙醇的百分浓度为5%-25%(v/v)。9. application according to claim 8, is characterized in that, in initial reaction system, the mass percentage concentration of substrate is 1%-30% (w/v); The percentage concentration of isopropanol is 5% %-25% (v/v). 10.根据权利要求8所述的应用,其特征在于,所述共固载催化剂的用量为底物质量的20%-100%(w/w);所述辅酶NADP+的用量为底物用量的0.003%-0.01%(w/w)。10. The application according to claim 8, wherein the consumption of the co-immobilized catalyst is 20%-100% (w/w) of the mass of the substrate; the consumption of the coenzyme NADP + is the consumption of the substrate 0.003%-0.01% (w/w).
CN202010570195.9A 2020-06-21 2020-06-21 Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof Pending CN111686809A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010570195.9A CN111686809A (en) 2020-06-21 2020-06-21 Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010570195.9A CN111686809A (en) 2020-06-21 2020-06-21 Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN111686809A true CN111686809A (en) 2020-09-22

Family

ID=72482500

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010570195.9A Pending CN111686809A (en) 2020-06-21 2020-06-21 Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN111686809A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375801A (en) * 2020-10-22 2021-02-19 复旦大学 Micro-reaction system and method for continuously preparing (R) -3-hydroxy-5-hexenoic acid ester by using same
CN112501235A (en) * 2020-11-19 2021-03-16 华东师范大学 Method for preparing breynolone by using monoalcohol ketone acetate
CN115992107A (en) * 2022-12-14 2023-04-21 江苏海洋大学 A kind of ketoreductase and its application

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679925A (en) * 2005-02-05 2005-10-12 复旦大学 Sustained-release microsphere preparation containing staphylokinase mutant and preparation method thereof
US20090061499A1 (en) * 2006-03-13 2009-03-05 Lentikat's, A.S. Method for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel, their use and devices for their production
CN102352387A (en) * 2011-09-19 2012-02-15 尚科生物医药(上海)有限公司 Method for synthesizing non-natural amino acid by utilizing immobilized whole cell catalyst
CN103525800A (en) * 2013-10-18 2014-01-22 江苏辉腾生物医药科技有限公司 Preparation method and application of polyvinyl alcohol immobilized acylase
CN107119081A (en) * 2017-05-26 2017-09-01 复旦大学 It is prepared by one kind(R)The method of the hexene acid esters of 3 hydroxyl 5
WO2018090929A1 (en) * 2016-11-16 2018-05-24 中国医药工业研究总院 Method for biologically preparing (1r,2s)-2-(3,4-difluorophenyl)cyclopropanamine d-mandelate (i)
CN108251465A (en) * 2016-12-28 2018-07-06 浙江京新药业股份有限公司 A kind of enzymatic-process preparation method of esomeprazole
CN108359626A (en) * 2018-01-05 2018-08-03 复旦大学 It a kind of engineering bacteria and its is preparing(R)Application in -3- hydroxyl -5- hexene acid esters
CN110643587A (en) * 2019-10-29 2020-01-03 杭州唯泰生物药业有限公司 Method for preparing nicotinamide adenine dinucleotide phosphate by enzyme method

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679925A (en) * 2005-02-05 2005-10-12 复旦大学 Sustained-release microsphere preparation containing staphylokinase mutant and preparation method thereof
US20090061499A1 (en) * 2006-03-13 2009-03-05 Lentikat's, A.S. Method for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel, their use and devices for their production
CN102352387A (en) * 2011-09-19 2012-02-15 尚科生物医药(上海)有限公司 Method for synthesizing non-natural amino acid by utilizing immobilized whole cell catalyst
CN103525800A (en) * 2013-10-18 2014-01-22 江苏辉腾生物医药科技有限公司 Preparation method and application of polyvinyl alcohol immobilized acylase
WO2018090929A1 (en) * 2016-11-16 2018-05-24 中国医药工业研究总院 Method for biologically preparing (1r,2s)-2-(3,4-difluorophenyl)cyclopropanamine d-mandelate (i)
CN108251465A (en) * 2016-12-28 2018-07-06 浙江京新药业股份有限公司 A kind of enzymatic-process preparation method of esomeprazole
CN107119081A (en) * 2017-05-26 2017-09-01 复旦大学 It is prepared by one kind(R)The method of the hexene acid esters of 3 hydroxyl 5
CN108359626A (en) * 2018-01-05 2018-08-03 复旦大学 It a kind of engineering bacteria and its is preparing(R)Application in -3- hydroxyl -5- hexene acid esters
CN110643587A (en) * 2019-10-29 2020-01-03 杭州唯泰生物药业有限公司 Method for preparing nicotinamide adenine dinucleotide phosphate by enzyme method

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375801A (en) * 2020-10-22 2021-02-19 复旦大学 Micro-reaction system and method for continuously preparing (R) -3-hydroxy-5-hexenoic acid ester by using same
US11913055B2 (en) 2020-10-22 2024-02-27 Fudan University Continuous flow method for preparing (R)-3-hydroxy-5-hexenoate
CN112501235A (en) * 2020-11-19 2021-03-16 华东师范大学 Method for preparing breynolone by using monoalcohol ketone acetate
CN112501235B (en) * 2020-11-19 2022-12-02 华东师范大学 Method for preparing breynolone by using monoalcohol ketone acetate
CN115992107A (en) * 2022-12-14 2023-04-21 江苏海洋大学 A kind of ketoreductase and its application

Similar Documents

Publication Publication Date Title
US10526622B2 (en) Preparation method for (R)-3-hydroxyl-5-hexenoate
CN103333942B (en) A synthetic method for (R)-praziquantel
CN111686809A (en) Carbonyl reductase/isopropanol dehydrogenase co-immobilized catalyst and preparation method and application thereof
CN105624128B (en) Immobilized monoamine oxidase and application thereof in synthesis of chiral azabicyclo compound
CN112375801A (en) Micro-reaction system and method for continuously preparing (R) -3-hydroxy-5-hexenoic acid ester by using same
CN119059976A (en) A method for preparing a chiral intermediate of zavigipan
CN105153110A (en) A kind of synthetic method of atorvastatin calcium chiral intermediate
CN108359626B (en) Engineering bacterium and application thereof in preparation of (R) -3-hydroxy-5-hexenoic acid ester
CN112708644B (en) Preparation method of florfenicol intermediate
WO2017092197A1 (en) Method for enzymatic resolution of isavuconazole intermediate
CN118724687A (en) Method for synthesizing 4-hexene-3-one using zinc chloride as catalyst
CN114539039B (en) A method for the synthesis of chiral fluorophenylethyl alcohol through photo-enzyme catalysis
CN113881720B (en) Transaminase and catalytic preparation method using same
CN111849954B (en) HMFO @ MOFs composite material and preparation method and application thereof
CN111808893B (en) Novel biological preparation method of amino alcohol drug intermediate
CN103409478B (en) Method for synthesizing biotin intermediate lactone through chemical enzyme method
CN110092726B (en) Synthesis method of Bictegravir intermediate
CN112322676A (en) Method for preparing fluvastatin through enzyme catalysis
CN105925558A (en) Compound immobilized enzyme used for preparing statins and preparation method of compound immobilized enzyme
CN112645952A (en) Synthetic method of (R) - (+) -9- (2-hydroxypropyl) adenine
CN115851778B (en) Thermophilic alkene reductase from aspergillus flavus, expression vector and application thereof
WO2019123311A1 (en) Process for preparing intermediates for the synthesis of optically active beta-amino alcohols by enzymatic reduction and novel synthesis intermediates
CN120843450A (en) A P450 hydroxylase and its application in synthesizing chiral dihydrofuran compounds
CN101898990A (en) Microbial system catalyzed method for synthesizing chiral azetidine amides and carboxylic acid compounds
JPH0823997A (en) Production of optically active 1,2-diol

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200922

WD01 Invention patent application deemed withdrawn after publication